Duke researchers use gene therapy to direct stem cells into becoming new cartilage on a synthetic scaffold even after implantation into a living body
By combining a synthetic scaffolding material with gene delivery techniques, researchers at Duke University are getting closer to being able to generate replacement cartilage where it’s needed in the body.
Performing tissue repair with stem cells typically requires applying copious amounts of growth factor proteins—a task that is very expensive and becomes challenging once the developing material is implanted within a body. In a new study, however, Duke researchers found a way around this limitation by genetically altering the stem cells to make the necessary growth factors all on their own.
They incorporated viruses used to deliver gene therapy to the stem cells into a synthetic material that serves as a template for tissue growth. The resulting material is like a computer; the scaffold provides the hardware and the virus provides the software that programs the stem cells to produce the desired tissue.
The study appears online the week of Feb. 17 in the Proceedings of the National Academy of Sciences.
Farshid Guilak, director of orthopaedic research at Duke University Medical Center, has spent years developing biodegradable synthetic scaffolding that mimics the mechanical properties of cartilage. One challenge he and all biomedical researchers face is getting stem cells to form cartilage within and around the scaffolding, especially after it is implanted into a living being.
The traditional approach has been to introduce growth factor proteins, which signal the stem cells to differentiate into cartilage. Once the process is under way, the growing cartilage can be implanted where needed.
“But a major limitation in engineering tissue replacements has been the difficulty in delivering growth factors to the stem cells once they are implanted in the body,” said Guilak, who is also a professor in Duke’s Department of Biomedical Engineering. “There’s a limited amount of growth factor that you can put into the scaffolding, and once it’s released, it’s all gone. We need a method for long-term delivery of growth factors, and that’s where the gene therapy comes in.”
The Latest on: Replacement Tissue
[google_news title=”” keyword=”Replacement Tissue” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Replacement Tissue
- Tooth Regeneration Market To Reach USD 8.5 Billion By 2032 | DataHorizzon Researchon May 11, 2024 at 5:29 am
The tooth regeneration market size was valued at USD 4.9 Billion in 2023 and is expected to reach a market size of USD 8.5 Billion by 2032 at a CAGR of 6.3%.Fort Collins, Colorado (GLOBE NEWSWIRE) -- ...
- 'World first' for double hand transplant patienton May 9, 2024 at 12:30 pm
A woman who had a double hand transplant has undergone pioneering NHS treatment to prevent her body rejecting them. Tanya Shepherd, from Hull, became the UK’s first female recipient of two replacement ...
- Edwards launches Sapien 3 Ultra Resilia TAVR in Europeon May 9, 2024 at 6:28 am
Sapien 3 Ultra Resilia is the only transcatheter aortic valve replacement (TAVR) system incorporating the company’s Resilia tissue technology. Edwards designed the Resilia technology to extend the ...
- Revolutionizing Regenerative Medicine: Groundbreaking Biomaterial for Tissue Growthon May 6, 2024 at 10:29 am
An international group of bioengineers and chemists from Rice University and the University of Houston have made great progress toward developing a biomaterial that may be utilized to cultivate ...
- A 'Moonshot': a living biological knee replacementon May 4, 2024 at 5:00 pm
The other option involves growing replacement tissue within 30 days using the patient’s own cells. These processes do not grow brand new knees, but rather stem cells and tissues that are then ...
- Exactech Strengthens Position as Soft Tissue Balancing Technology Leader with New Patentson April 21, 2024 at 5:00 pm
GAINESVILLE, Fla., April 22, 2024 /PRNewswire/ -- Exactech, a developer and producer of innovative implants, instrumentation and smart technologies for joint replacement surgery, announced today ...
- Experimental Ovarian Tissue Freezing Could Delay Menopause, but Experts Are Weighing the Riskson April 21, 2024 at 5:00 pm
question the need for ovarian tissue transplantation, given that hormone replacement therapy, or HRT, is already an effective and readily accessible intervention to manage menopause symptoms.
- Will Heart Valve Tissue Engineering Change the World?on April 14, 2024 at 5:00 pm
Nat Clin Pract Cardiovasc Med. 2005;2(2):60-61. Several strategies for heart valve tissue engineering are evolving. They include the use of decellularized allogenic or xenogenic valve matrices ...
- All you need to know about stem cellson April 5, 2024 at 5:00 pm
A stem cell is a "mother cell" with the ability to develop into different kinds of tissue. What are the potential benefits of this research? • Imagine being able to grow replacement brain ...
- Multiple biomaterials for immediate implant placement tissue repair: Current status and future perspectiveson March 29, 2024 at 11:21 am
Tissue engineering emerges as an effective strategy, offering new possibilities beyond traditional biomaterials for bone replacement. This interdisciplinary approach aims to develop implants that ...
via Bing News